Keybanc Initiates Coverage On NeuroPace with Overweight Rating, Announces Price Target of $18

Keybanc analyst Brett Fishbin has initiated coverage on NeuroPace (NASDAQ: NPCE) with an Overweight rating. The firm has set a price target of $18 for the company's stock.